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SUMMARY
Apicomplexa parasites such as Toxoplasma gondii
target effectors to and across the boundary of their
parasitophorous vacuole (PV), resulting in host cell
subversion and potential presentation by MHC class
Imolecules for CD8 T cell recognition. The host-para-
site interface comprises the PV limiting membrane
and a highly curved, membranous intravacuolar
network (IVN) of uncertain function. Here, using a
cell-free minimal system, we dissect how membrane
tubules are shaped by the parasite effectors GRA2
and GRA6. We show that membrane association
regulates access of the GRA6 protective antigen to
the MHC I pathway in infected cells. Although inser-
tion of GRA6 in the PV membrane is key for immuno-
genicity, association of GRA6 with the IVN limits
presentation and curtails GRA6-specific CD8 re-
sponses in mice. Thus, membrane deformations of
the PV regulate access of antigens to the MHC class
I pathway, and the IVN may play a role in immune
modulation.
INTRODUCTION
The interplay between membrane proteins and their lipid envi-
ronment is increasingly recognized as regulating many cellular
processes (reviewed in Schmick and Bastiaens, 2014).
By providing the energy required for membrane deformation,
the physical action of specialized proteins, such as those con-
taining amphipathic alpha-helices (AAH), shapesmembrane cur-
vature (reviewed in Kozlov et al., 2014). Proteins containing AAH,
in which the hydrophobic amino acids (aa) are located on one
side of the helix while the polar, charged residues are located
on the opposite side, typically insert into one monolayer leaflet.
By virtue of interaction between the AAH positive charges and
the lipid bilayer negative charges, membranes may be deformed
into tubules (reviewed in Drin and Antonny, 2010).
Conversely, membrane curvature—and more extensively, the
lipid environment (thickness, composition)—often dictate trans-
membrane protein structure and function. The lipid environment
may influence translocation of molecules across membranes
(Phillips et al., 2009). For example, membrane curvature affects
the radius and permeability of pores made by the Staphylo-
coccus aureus a-hemolysin toxin (Tonnesen et al., 2014). How-
ever, whether membrane deformations regulate molecular ex-
changes between an intracellular parasite and its host, thereby
affecting host immune recognition of the parasite, remains
unexplored.
Toxoplasma gondii (T. gondii) is an obligate intracellular para-
site able to infect anywarm-blooded animal. In humans, T. gondii
is responsible for severe fetal abnormalities and for encephalitis
in immunocompromised individuals. Following host cell inva-
sion, T. gondii multiplies within a parasitophorous vacuole (PV)
segregated from the cytosol by a limiting membrane. This mem-
brane represents themajor interface with the host cell. PV forma-
tion results from the sequential secretion of parasite secretory
organelles called micronemes, rhoptries, and dense granules
(Sibley, 2011). Although some of the rhoptry content is injected
directly into the host cytosol upon initial contact, dense granule
material is thought to be massively secreted at the time of vacu-
ole formation and to be further exocytosed throughout the
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Figure 1. Association of the T. gondii Dominant Antigen GRA6 to Lipid Membranes of the PV Is Required for Efficient MHC I Presentation by
Infected Macrophages
(A) Schematic representation of the two HF10-containing antigenic constructs transfected in TgCEP GFP LUC. GRA6-HF10 comprises the Nter GRA6I-TM
GRA6I-Cter GRA6I (minus the last ten residues)-HF10 domains. SAG1-GRA6-HF10 comprises the SAG1 (minus glycosylphosphatidylinositol GPI)-TM GRA6I-
Cter GRA6I (minus the last ten residues)-HF10 domains. Numbers represent the size of each domain in aa.
(B) Solubility profile of GRA6-HF10 and SAG1-GRA6-HF10 in overnight-infected HFF after mechanical disruption and fractionation by low-speed and high-speed
centrifugations. After elimination of the intact parasites and larger debris, the indicated antigenic (Ag) constructs present in the LSS, HSP (insoluble, membrane
bound), or HSS (soluble) fractions were analyzed by western blot (WB) using anti-HF10 rabbit antiserum or anti-GRA1 mAb. Histograms show the mean ± SD of
the HSP:HSS ratio, computed from three independent experiments.
(C) Subcellular localization of the GRA6-HF10 and SAG1-GRA6-HF10 antigenic constructs in 24-hr-infected HFF co-stained with anti-HF10 and anti-GRA1
(vacuolar lumen) or anti-GRA3 (PV membrane). Examples are representative of 20 PVs analyzed. Scale bar, 5 mm.
(legend continued on next page)
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intracellular life of the parasite within its PV (Carruthers and Sib-
ley, 1997; Leriche and Dubremetz, 1990). A prominent feature of
the PV is the presence of an intravacuolar network (IVN), also
referred to as the membranous nanotubular network, made of
highly curved membrane tubules that connect the parasites
together and to the PV membrane (Cesbron-Delauw et al.,
2008; Sibley et al., 1995). We previously reported that two pro-
teins secreted from the dense granules, GRA2 (Mercier et al.,
2002; Travier et al., 2008) and GRA6 (Lecordier et al., 1995;
Mercier et al., 2002), are implicated in IVN biogenesis. Shortly
following their release into the vacuolar space, GRA2 and
GRA6 localize to the posterior end of the parasite, where they
associate with membrane whorls and vesicles that give rise to
the IVN (Labruyere et al., 1999; Sibley et al., 1995). Deletion of
the GRA2 gene and complementation with truncated versions
of GRA2 indicated that both its N-terminal domain and its three
central AAH are necessary for IVN formation (Mercier et al.,
2002; Travier et al., 2008). The N-terminal domain of GRA6 is
crucial for association with the IVN (Gendrin et al., 2010), and,
importantly, disruption of the GRA6 gene led to replacement of
the IVN by smaller tubules and vesicles (Mercier et al., 2002).
These data suggested a model where GRA6 may help stabilize
the membrane tubules initiated by GRA2 (Mercier et al., 2002).
The IVN was initially proposed as a structural basis for ordered
arrangement and synchronous division of the dividing parasites
(Magno et al., 2005; Travier et al., 2008). The IVN may also be
involved in virulence (Mercier et al., 1998) by helping to route
parasite rhoptry effectors released in the host cytosol back to
the PV membrane, thereby preventing PV destruction by immu-
nity-related GTPases (Niedelman et al., 2012). More recently, the
IVN has been implicated in the ingestion of host cytosolic mate-
rial by the parasite (Dou et al., 2014). However, the exact molec-
ular bases underlying IVN biogenesis as well as its function(s)
remain ill defined.
Detection of T. gondii intrusion by CD8 T cells relies on the
recognition of short antigenic peptides (8–10 aa) presented by
major histocompatibility complex (MHC) class I (MHC I) mole-
cules at the surface of infected cells. The generation of antigenic
peptides from endogenous sources typically requires process-
ing by cytosolic proteases, transport into the ER, trimming by
ER-resident aminopeptidases, and loading onto peptide-recep-
tive MHC I molecules (Blum et al., 2013). In the case of T. gondii,
resistance to infection requires CD8 T cells (Parker et al., 1991;
Suzuki and Remington, 1990), and MHC I processing is depen-
dent on proteasome and TAP activity (Bertholet et al., 2006;
Blanchard et al., 2008; Grover et al., 2014; Gubbels et al.,
2005), suggesting that parasite antigenic precursors have
to transit through the cytosol. Passage of T. gondii antigens to
the cytosol may be facilitated by the recruitment of the host
ER-associated degradation (ERAD) machinery onto the PV
membrane (Cebrian et al., 2011; Goldszmid et al., 2009). How-
ever, the details of this export pathway remain elusive, and its
mode of regulation has not been elucidated.
Here, we examined how membranes at the host-parasite
interface that represent potential exit gates beyond the vacuolar
space may regulate immunogenicity of T. gondii proteins. Using
in vitro tubulation assays in a cell-free system, reverse genetics
in T. gondii, and antigen presentation measurements, we report
that insertion of a T. gondii dominant antigen (GRA6) at the PV
membrane is key for immunogenicity. However, association of
this antigen with the IVN limits its presentation and curtails the
development of specific CD8 responses in mice.
RESULTS
Membrane Association of the T. gondii Antigen GRA6 Is
Beneficial for MHC I Presentation
To determine the impact of protein binding to membranes on
MHC I processing in parasite-infected cells, we set out to
disturb the trafficking of a membrane-bound T. gondii antigen.
We focused on the GRA6 antigen. In mice infected by type II
T. gondii, GRA6 gives rise to a naturally processed decamer
epitope (HPGSVNEFDF; namely, HF10), which is presented by
MHC I Ld and elicits dominant and protective CD8 responses
(Blanchard et al., 2008; Feliu et al., 2013). We chose to work
with GRA6 because it is known to coexist as both a soluble
form and a transmembrane form (Gendrin et al., 2010), inserted
in membranes of the PV with a preferential IVN localization (Lab-
ruyere et al., 1999). Based on our previous observation that the
N-terminal domain of GRA6 is responsible for its selective mem-
brane association (Gendrin et al., 2010), we designed an anti-
genic construct bearing the HF10 epitope but comprising the
SAG1 N-terminal domain instead of the natural GRA6 N-terminal
domain (Figure 1A). This mutant was expected to behave mostly
as a soluble protein within the vacuolar space. We stably trans-
fected the control and mutant constructs into type III parasites
(TgCEPGFP LUC, shortened here as TgCEP (see Table S1) (Feliu
et al., 2013), which are naturally ‘‘HF10 null’’ due to poly-
morphisms in the GRA6 C-terminal domain. As expected, and
despite the putative 19-residue transmembrane (TM) domain,
biochemical fractionation of infected fibroblasts established
that the antigenic construct bearing the SAG1N-terminal domain
was preferentially soluble, while the GRA6-HF10 control was
equally distributed between the soluble and membrane fractions
(Figure 1B). As a control, the purely soluble GRA1 protein (Sibley
et al., 1995) was found exclusively in the high-speed supernatant
(Figure 1B). These data were consistent with immunofluores-
cence analyses of the two antigenic constructs in combination
with prototypical markers of the PV membrane (GRA3) and the
PV lumen (GRA1). GRA6-HF10 was present both at the PV
(D) Upper panel: secretion level of GRA6-HF10 (black line) and SAG1-GRA6-HF10 (gray line) in BMM infected (GFP+) with the indicated parasite line, for the
indicated time and dose, detected with AF647-coupled anti-HF10. Lower panel: secretion level of endogenous GRA6III in BMM infected (GFP
+) with the indicated
parasite line, detected with AF647-coupled anti-HY10. Controls show labelings of GFP cells from infected cultures (dotted lines) and BMM not mixed with
tachyzoites (tinted histogram).
(E) Dot plots showing the proportion of GFP+ BMM (i.e., infected cells) measured at the time of the antigen presentation assay.
(F) HF10 presentation by BMM infected in the same conditions as in (D) and (E), assessed with the CTgEZ.4 T cell hybridoma.
(D)–(F) are representative of two independent experiments with similar results.
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membrane and in the PV lumen, most likely bound to the
IVN, which cannot be resolved by light microscopy (Figure 1C,
left panels). In contrast, the SAG1-GRA6-HF10 construct was
mostly luminal and displayed limited overlap with the GRA3 PV
membrane marker (Figure 1C, right panels).
When used to infect bone-marrow-derived macrophages
(BMM), these two T. gondii lines revealed that HF10 presenta-
tion from the mostly soluble antigen (SAG1-GRA6-HF10) was
dramatically reduced (Figure S1A). This difference could be
attributed neither to impaired infectivity (FigureS1B) nor to defec-
tive expression of SAG1-GRA6-HF10 by tachyzoites, since it was
actually 3-fold more abundant than GRA6-HF10 (Figure S1C).
As MHC I presentation of T. gondii antigens strongly relies on
active secretion into the PV (Gregg et al., 2011), we sought to
quantify the amount of GRA6 released into the PV by both para-
site lines. To this aim, we designed a flow-cytometry-based
assay that takes advantage of the fact that the saponin detergent
permeabilizes both the host cell plasma membrane and the
PV membrane, but not the intra-tachyzoite dense granules (Fig-
ures S1D–S1F). Thus, dense-granule-secreted material present
within the host cell, but outside of the parasite, could be selec-
tively quantified by flow cytometry. Using an anti-HF10 antibody,
we consistently noticed a 3-fold lower level of secretion of
SAG1-GRA6-HF10 in infected macrophages (Figure S1G, upper
panel). To explore the possibility that lower secretion of the
mostly soluble antigen may explain its impaired presentation,
we adjusted the infection conditions in order to obtain compara-
ble levels of secretion of membrane-bound and soluble antigens
(Figure 1D, top). To this aim, we reduced the dose and duration of
infection with TgCEPGRA6-HF10 tachyzoites (MOI, 1:1, 7 hr), as
compared to TgCEP SAG1-GRA6-HF10 tachyzoites (MOI, 2.5:1,
24 hr). Consequently, as expected, BMM incubated with TgCEP
GRA6-HF10were infected at a lower rate (Figure 1E), and endog-
enousGRA6III was less abundant in the host cells (Figure 1D, bot-
tom). However, MHC I presentation of the membrane-bound
GRA6-HF10 antigen was still enhanced (Figure 1F). In conclu-
sion, disrupting the association of a T. gondii dense granule anti-
gen with vacuolar membranes impairs MHC I presentation by
T. gondii-infected cells independently of the efficiency of dense
granule secretion into the PV.
GRA2Amphipathic aHelices, in Cooperationwith GRA6,
Deform Lipid Vesicles into Elongated Tubules, akin to
Those of the IVN
Vacuolar membranes include the PV membrane and the IVN. To
gain more insight into how these two membranous structures,
that display different curvatures, could influence MHC I presen-
tation, we sought to dissect how the tubules of the IVN are
shaped. We had previously shown indirectly that IVN biogenesis
requires GRA2 to initiate themembranous tubules of the IVN and
GRA6 to stabilize them (Mercier et al., 2002). To establish the
respective implications of each effector, we developed aminimal
cell-free system to study the deformations of extruded large uni-
lamellar vesicles (LUV) by recombinant GRA2 and/or GRA6. After
characterizing the biophysical properties of the two recombinant
proteins (Bittame et al., 2015), we analyzed the ability of rGRA2
or of a truncated rGRA2 mutant, from which the three AAH
(rGRA2 DAAH) were deleted (Figure 2A), to bind to and deform
LUV formed of lipids extracted from HeLa cells. Comparisons
of LUV extruded at various diameters revealed that rGRA2
boundmost efficiently to vesicles extruded at a 100-nmdiameter
(data not shown). The incubation products were then fraction-
ated on a step gradient of sucrose. Iodine labeling revealed
that the majority of the glycerophospholipid pool was present
within the 0%–10% sucrose fractions (Figure 2B, upper panel).
Even though a substantial amount of rGRA2 remained in the
30% and 40% sucrose fractions, indicative of protein aggrega-
tion, 20% of the rGRA2 pool floated up to the 10% sucrose
fraction, and some rGRA2 was detected in the 0% and 5% su-
crose fractions (Figure 2B, middle panel). In contrast, rGRA2
DAAH was confined in the bottom 30%–40% sucrose fractions
(Figure 2B, lower panel). These results were not the conse-
quence of inherent rGRA2 DAAH instability, given that this
protein folds in random coil (Bittame et al., 2015). Therefore,
our data show that rGRA2 association with LUV depends
on the domains of its AAH. Next, we evaluated the ability of
rGRA2 to deformmembranes by analyzing the LUV-protein incu-
bation products by transmission electron microscopy (TEM). Tu-
bules were detected at a lipid:protein ratio of 50:1, only when
LUV were incubated with rGRA2 and not with rGRA2 DAAH (Fig-
ures 2C and 2D and S2A). In these conditions, the tubules were,
on average, 178 ± 69 nm long, with a diameter of 25–33 nm (Ta-
ble 1). As HeLa-extruded LUV have a complex lipid composition,
we investigated whether the AAH of rGRA2 would exhibit selec-
tive affinity for particular membrane lipids. We incubated rGRA2
or rGRA2 DAAH with nitrocellulose membranes spotted with
defined synthetic lipids (‘‘fat blots’’). Both proteins displayed
similar intense reactivity with phosphatidylinositol (4)-mono-
phosphate (PI(4)P), phosphatidylinositol (3,4,5)-trisphosphate
(PI(3,4,5)P3), and cardiolipin (CL), as well as similar weak reac-
tivity with phosphatidylserine (PS). Only rGRA2 showed specific
reactivity with phosphatidylinositol (4,5)-bisphosphate (PI(4,5)
P2) (Figure 2E). Accordingly, when rGRA2 was mixed with LUV
of different (known or undetermined) lipid compositions; i.e.,
phosphatidylcholine (PC) + phosphatidylethanolamine (PE),
PC + PE + PI(4,5)P2 or total lipids extracted from HeLa cells,
rGRA2 preferentially bound to HeLa LUV and LUV containing
PI(4,5)P2 (Figure S2B). These results indicate that (1) rGRA2 as-
sociates with 100-nm-diameter membrane vesicles through
specific interactions between its AAH and PI(4,5)P2 lipids, and
(2) rGRA2 has the ability to deform these vesicles into membrane
tubules, although the requirement for PI(4,5)P2 in the tubulation
process has not been investigated.
To explore the role of GRA6 in the tubulation process, we
mixed recombinant GRA6 (rGRA6; Figure 3A) with HeLa LUV.
We verified that rGRA6 could directly associate with the LUV
(Figure 3B) and examined the incubation products by TEM.
LUV incubated with rGRA6 appeared aggregated, but no tubule
was observed (Figure 3C; Table 1). As a control, LUV incubated
without rGRA6 were homogenously distributed on the grids (Fig-
ure 3C, right panel). These results suggest that rGRA6 may act
by tethering membrane vesicles.
To examine the potential synergistic role of rGRA2 and rGRA6,
we co-incubated 100-nm-diameter LUV with a mixture of rGRA2
and rGRA6at a lipid:protein ratio of 50:1. Since the relativepropor-
tions of rGRA2 and rGRA6 in the PV are not known, we empirically
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tested three different rGRA2:rGRA6 ratios. Both the 1:1 and the
25:1 ratios resulted in aggregated or coalescent LUV but not tu-
bule (Figure S2C). By contrast, the 10:1 ratio led to ten times
more abundant tubules than with rGRA2 alone, and tubules had
a mean length of 150 ± 44 nm and a mean diameter of 20.7 ±
2.0nm(Figure3D;Table1).Consistently, amoreabundant fraction
of rGRA2 floated up to the lightest sucrose fractions (0% and 5%)
at the 10:1 ratio than at the 25:1 ratio (Figure S2D).
Taken together, these data suggest that there is a window
of optimal rGRA2:rGRA6 proportions for tubule formation, and
they support the notion that, by a process of vesicle tethering
and tubulation, GRA6 and GRA2 are necessary and sufficient
to deform vacuolar lipid vesicles into the elongatedmembranous
tubules that constitute the IVN.
GRA2-Dependent IVN Biogenesis in Dendritic Cells and
Macrophages
Knowing that membrane association positively regulates MHC I
presentation of a membrane-bound antigen, we investigated
how highly curved IVN membranes specifically impact this pro-
cess. First, we selected the genetically amenable type I TgRH to
assess the consequences of GRA2 deletion on presentation of
the GRA6-derived epitope. Since TgRH is naturally devoid of the
HF10 epitope, we engineered this strain to express the GRA6-
HF10 antigen using an existing GRA6(I)-deficient line (Mercier
et al., 2002). The resulting parasites are referred to as TgRH
GRA6-HF10 for simplicity (Figure S3; Table S1). Then, we deleted
GRA2 by double-homologous recombination to obtain TgRH
GRA6-HF10 Dgra2 and generated the control complemented
parasite TgRH GRA6-HF10 Dgra2/GRA2. Given that the IVN had
been reported in fibroblasts but never in immune cells, we first
examined the presence and shape of the IVN in parasite-infected,
bone-marrow-derived dendritic cells (BMDC) by TEM. In BMDC
infected with TgRH GRA6-HF10 or the complemented TgRH
GRA6-HF10 Dgra2/GRA2, membranous tubulovesicular material
forming a network was observed within the PV lumen around the
parasites (Figures S4A and S4C). In contrast, IVN tubular struc-
tures were absent from PVs containing GRA2-deficient parasites.
In these PVs, only proteinaceous granular material was detected
(Figure S4B). Similar observations were made using infected
BMM (data not shown). Therefore, the IVN is also generated in a
GRA2-dependentmanner inprofessional antigen-presentingcells
Figure 2. rGRA2 Induces Tubulation of
Large Unilamellar Vesicles through Its
Amphipathic a Helices, which Bind to
PI(4,5)P2 Lipids
(A) Schematic representation of the wild-type and
AAH-deleted GRA2 recombinant proteins. The
white boxes at both extremities indicate linkers (L),
and numbers represent the size of each domain in
aa. The recombinant proteins were tagged with
polyhistidine residues at their N andC termini (Nter
and Cter, respectively) (HisX6).
(B) Analysis of the incubation product of rGRA2 or
rGRA2 DAAH with HeLa LUV extruded at 100 nm.
Each protein was incubated with HeLa LUV at a
lipid:protein ratio of 25:1. The binding mixture was
mixed with 80% sucrose, loaded at the bottom of
a tube, overlaid with a step sucrose gradient 40%–
0% (bottom to top), and ultracentrifuged. Five
microliters of each fraction was spotted onto
nitrocellulose, and unsaturated phospholipids
were revealed by fumigation with iodine (upper
panel). An equal volume of each fraction was
analyzed by western blot (WB) probed with anti-
GRA2 mAb (middle and lower panels).
(C and D) TEM analysis of incubation products of
rGRA2 (C) or rGRA2 DAAH (D) incubated with
HeLa LUV extruded at 100 nm (lipid:protein, 50:1).
A representative image is shown for each condi-
tion. The right image represents a magnified view
of the area contained in the white box.
(E) Lipid-binding analysis of rGRA2 or rGRA2
DAAH by lipid-protein overlay. Recombinant
proteins were incubated on lipid strips and
probed with anti-GRA2 mAb. TG, triglyceride;
DAG, diacylglycerol; PA, phosphatidic acid; PC,
phosphatidylcholine; PG, phosphatidylglycerol;
PI, phosphatidylinositol; Chol, cholesterol; SM,
sphingomyelin; SGC, 3-sulfogalactosylceramide.
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(APC). These results establish a model to study the role of the IVN
in MHC I presentation by infected APC.
The IVN Inhibits MHC I Presentation of the Membrane-
Bound T. gondii Antigen GRA6
To interrogate the role of the IVN in MHC I presentation of the
membrane-bound GRA6 antigen, we infected BMM in vitro with
one of three parasite strains: TgRH GRA6-HF10, TgRH GRA6-
HF10 Dgra2, or TgRH GRA6-HF10 Dgra2/GRA2. Despite similar
infection rates (Figure 4A), HF10 presentation was enhanced by
more than 8-fold when GRA2 was deleted (Figure 4B). This was
related neither to a difference in GRA6 expression by the trans-
genic parasites (Figure 4C) nor to a global increase in MHC I pre-
sentation capacity induced by TgRH GRA6-HF10 Dgra2, since
presentation of an exogenously pulsed peptide, the SM9 peptide
derived from theGRA4antigen,was similar in all cases (Figure4D).
AsGRA2andGRA6may (directly or indirectly) interact, absenceof
GRA2 could enhance secretion of GRA6 into the vacuolar space.
Using the aforementioned ‘‘secretion assay,’’ we found a slight
(20%) increase in the amount of vacuolar GRA6 inBMM infected
with GRA2-deficient tachyzoites (Figure S5A). Adjustment of the
infection conditions to equalize secretion (i.e., shorter infection
time with TgRHGRA6-HF10 Dgra2) did not abolish the difference
in HF10 presentation (Figure S5B), indicating that the IVN de-
creases presentation of the membrane-bound GRA6 indepen-
dently from a potential effect on its secretion.
The availability of type II parasites deficient in non-homolo-
gous end joining, in which gene disruption is facilitated (Fox
et al., 2011), then allowed us to address the role of GRA2 in
the presentation of HF10 in its natural GRA6II context. Disruption
of GRA2 in TgPru Dku80 increased presentation of the HF10
peptide by infected BMM (Figure 4E), while both the infection
rate (Figure 4F) and the level of GRA6II protein expression (Fig-
ure 4G) were similar. Again, themodestly increasedGRA6 secre-
tion observed for TgPru Dgra2was not responsible for enhanced
HF10 presentation (Figure S5D).
Importantly, similar findings were made with BMDC, which
constitute the most potent cell subset for priming parasite-spe-
cific CD8 T cells (Figures S5E–S5J).
Next, we questioned whether the increased MHC I presenta-
tion in the absence of GRA2 applies to all T. gondii-derived anti-
gens, regardless of their membrane association properties. To
this aim, we deletedGRA2 in a parasite strain expressing the sol-
uble SAG1-OVAmodel antigen (TgRHYFPSAG1-OVA) (Gubbels
et al., 2005). Neither the amount of SAG1-OVA expressed by ta-
chyzoites (Figure 4H) nor the infectivity of the parasites (Figure 4I)
were affected by GRA2 deletion. OVA-derived SL8 presentation
by MHC I Kb was modestly increased (2-fold) with GRA2-defi-
cient parasites (Figure 4J), suggesting that the GRA2-mediated
negative regulation of MHC I presentation by IVN membranes
is selective, with a more pronounced effect for IVN membrane-
associated antigens.
To strengthen the relevance of these findings, we next investi-
gated the influence of the IVN on the expansion of CD8 T cell
responses in vivo using a protocol of prime/boost immunization
with irradiated tachyzoites, which can still generate the IVN
(Figure 5A and S6A–S6D). Four days following the second immu-
nization (i.e., at day 25), we assessed the magnitude of CD8 T cell
responses to the dominant GRA6-derived HF10 peptide and the
subdominant Tgd057-derived SVL8 peptide (Wilson et al., 2010)
in the spleen (Figure 5B) and the peritoneum (Figure 5C). In com-
parison to GRA2-expressing parasites, TgRH GRA6-HF10 Dgra2
elicited a significantly higher proportion of HF10-reactive CD8
T cells in both tissues examined, whereas no statistically signifi-
cant difference was observed for the Tgd057-specific response.
Subcellular fractionation showed that most of the Tgd057 protein
waspresent in the soluble fraction (Figure5D). Accordingly, immu-
nofluorescence analyses revealed the presence of Tgd057 within
the PV lumen, with limited overlap with GRA5, a marker of the
PV membrane (Figure 5E). At last, enhanced HF10-specific CD8
responses were also detected when mice were injected with live
TgPru tachyzoites deficient for GRA2, although interpretations
are complicated by the dramatically reduced virulence of the
TgPru Dgra2 (Figures S6E–S6G). In summary, our in vitro and
in vivodatastrongly suggest thatmembranesof the IVNnegatively
regulate MHC I presentation and CD8 T cell responses to mem-
brane-bound T. gondii antigens.
Disruption of the IVN Increases GRA6 Targeting to the
PV Membrane
Intriguingly, although membrane binding of the T. gondii antigen
GRA6 was beneficial to its MHC I presentation, targeting to the
IVN was detrimental. To understand this seemingly paradoxical
result, we analyzed the subcellular localization and solubility
Table 1. Influence of rGRA2 and rGRA6 on Tubule Number, Length, and Diameter
Conditions
of LUV
Incubation
No. of Fields
Observed
(1.8 mm2/field)
Total
Surface
Counted (mm2)
Total
No. of
Tubules
No. of
Tubules/mm2
Tubule Length
(mean ± SD, in nm)
Range of Tubule
Length (in nm)
Tubule Diameter
(mean ± SD, in nm)
LUV only 13 42.1 0 0.0 NA NA NA
LUV + rGRA2 14 45.4 328 7.2 178 ± 69 90–350 28.8 ± 4.0
LUV + rGRA2 DAAH 14 45.4 16 0.4 ND ND ND
LUV + rGRA6 11 35.6 0 0.0 NA NA NA
LUV + rGRA2 + rGRA6 7 22.7 1,736 76.5 150 ± 44 (NS) 80–260 20.7 ± 2.0***
Quantifications were performed on HeLa LUV extruded at 100 nm and incubated at a lipid:protein ratio of 50:1. For rGRA2 + rGRA6 co-incubation, the
rGRA2:rGRA6 ratio was 10:1. To compute the total number of tubules, tubules were enumerated from the indicated number of 1.8 mm2 fields of view.
Measurements of length and diameter were done on a sampling of 26 (rGRA2) and 28 (rGRA2 + rGRA6) straight tubules, selected from at least five
different fields. p values were calculated with two-tailed non-parametric Mann-Whitney tests between the rGRA2 alone and the rGRA2 + rGRA6 con-
dition. ***p < 0.001; NS, p > 0.05; ND, not determined; NA, not applicable.
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profile of GRA6 in the presence or absence of the IVN. Biochem-
ical fractionation revealed that the proportion of soluble GRA6
was not altered by the deletion of GRA2 (Figure 6A). This largely
unchanged solubility profile indicated that, in the absence of the
IVN, GRA6 was likely targeted to other membranes of the PV,
such as its limiting membrane. To test this hypothesis, we
used confocal microscopy sections to quantify the fluorescence
signal of GRA6-HF10 present in the vicinity of the PV membrane
versus that contained in the entire PV (Figure 6B). Deletion of
GRA2 led to a preferential localization of GRA6 at the PV mem-
brane (Figure 6C). Thus, enhanced access of the membrane-
bound GRA6 antigen to the MHC I pathway correlates with its
redistribution at the PV membrane.
DISCUSSION
As a means of subverting, persisting, and propagating to new
hosts, intracellular protozoan parasites introduce many compo-
Figure 3. By Tethering Vesicles, rGRA6 Co-
operateswith rGRA2 toDeform Large Unila-
mellar Vesicles into Elongated Tubules akin
to the Tubular IVN
(A) Schematic representation of the wild-type
GRA6 recombinant protein. The white boxes at
both extremities indicate linkers (L), and numbers
represent the size of each domain in aa. The re-
combinant protein was tagged with polyhistidine
residues at its N and C termini (Nter and Cter,
respectively) (HisX6).
(B) Analysis of the incubation product of rGRA6
with HeLa LUV extruded at a 100-nm diameter, at
a lipid:protein ratio of 50:1. Following fractiona-
tion on a step sucrose gradient 40%–0% (bottom
to top), an equal volume of each fraction was
analyzed by western blot (WB) probed with rabbit
anti-GRA6 antiserum.
(C) TEM analysis of HeLa LUV extruded at a
100-nm diameter and incubated (left panel) or not
(right panel) with rGRA6 at a lipid:protein ratio
of 50:1.
(D) TEM analysis of the co-incubation of rGRA2
and rGRA6 with HeLa LUV extruded at 100 nm
(lipid:protein, 50:1; rGRA2:rGRA6, 10:1). The right
image represents a magnified view of the area
contained in thewhite box. Representative images
are shown.
nents into their host cells. A potential
‘‘side effect’’ is the processing of this ma-
terial for presentation by MHC class I
molecules, potentially resulting in im-
mune detection by CD8 T cells. The
T. gondii-secreted components can be
soluble or membrane bound and have
peculiar targeting locations including the
highly curved membranes of the IVN;
yet, how these membranes impact CD8
T cell responses was unexplored. Using
a cell-free system to study IVN biogen-
esis, we showed that, by cooperatively
binding to negatively charged lipids, GRA2 and GRA6 promote
the formation of membrane tubules by a process of vesicle teth-
ering (GRA6) and tubule formation (GRA2) (see the working
model in Figure S7). In PV containing GRA2-deficient parasites
(i.e., lacking the IVN to which GRA6 can bind), the membrane-
bound GRA6 was ‘‘freed up’’ to relocate in larger proportion to
the PV limiting membrane. We hypothesize that one conse-
quence of this relocation is the enhancement of MHC class I pre-
sentation of GRA6. In summary, we demonstrate that the binding
mode of a T. gondii antigen to membranes largely determines
MHC class I presentation by infected cells and the development
of CD8 T cell responses.
The significance of this work is at least 3-fold. First, our data
suggest that the IVN may play an immune modulatory role by
interfering with MHC class I processing of membrane-bound
vacuolar antigens. This adds a new potential function to the
already described roles for the IVN, such as host material uptake
(Dou et al., 2014) or intra-PV tachyzoite organization (Travier
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Figure 4. In Infected BMM, the IVN Decreases MHC Class I Presentation of the Membrane-Bound GRA6 Antigen
(A) Proportion of CMTMR+ BMM (i.e., infected cells) out of live BMM measured 6 hr post-infection.
(B) Ld-HF10 presentation by BMM infected for 24 hr with the indicated parasites, assessed with the CTgEZ.4 hybridoma.
(C) Western blot (WB) analysis showing the expression level of GRA6 and GRA2 in the indicated parasite lines, with SAG1 as a loading control.
(D) Exogenous presentation of synthetic GRA4-derived SM9 peptide pulsed on BMM previously infected with the indicated parasites for 24 hr, assessed with the
BDSM9Z hybridoma.
(E) Ld-HF10 presentation by BMM infected for 24 hr with TgPru or TgPru Dgra2, assessed with the CTgEZ.4 hybridoma.
(F) Proportion of CMTMR+ BMM (i.e., infected cells) out of live BMM measured 6 hr post-infection.
(legend continued on next page)
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et al., 2008). Second, beyond antigen processing, our results
suggest that membrane deformations (such as those forming
the IVN) could be key determinants for controlling the passage
of parasite proteins beyond the vacuolar boundary. Third, our
work identifies additional parameters regulating immunogenicity
of T. gondii antigens in the MHC class I pathway, an endeavor
that will be crucial in improving the design of T. gondii as a vac-
cine vector.
Why does membrane binding enhance MHC class I presenta-
tion in the context of T. gondii infection? One could envisage two
main hypotheses.
If anchored at the PV membrane with its C terminus exposed
to the host cell cytosol, then the GRA6 C-terminal domain (which
contains the HF10 epitope) could be cleaved and released into
the cytosol by an endopeptidase before its final processing by
the proteasome (Blanchard et al., 2008). Intriguingly, given the
recently reported NFAT4 stimulatory activity of the GRA6 C ter-
minus in type I T. gondii (Ma et al., 2014), such endopeptidase
could also modulate the innate signals triggered by the GRA6
C-terminal domain. In both scenarios, the nature of the involved
peptidase(s) is uncertain. Candidate enzymes include those
known to generate MHC class I peptides in the cytosol; e.g., in-
sulin-degrading enzyme (Parmentier et al., 2010), thimet oligo-
peptidase, or nardilysin (Kessler et al., 2011). Alternatively, given
the transmembrane nature of GRA6, the C-terminal fragment
may be released via intra-membrane proteolysis by enzymes
of the rhomboid class. Testing the involvement of these prote-
ases will first require us to determine the topology of GRA6 in
the PV membrane and to assess the impact of its topology on
presentation.
A second hypothesis to explain the higher immunogenicity of
membrane-bound versus soluble antigens could be their closer
proximity to a translocation machinery embedded within the
PV membrane. Such a machinery could involve the Sec61-
based translocon, a protein complex normally mediating ER-
to-cytosol retrotranslocation during the ERAD pathway. Sec61
has, indeed, been reported to be recruited from the host ER
onto the PV membrane and to facilitate vacuole-to-cytosol
export of the soluble SAG1-OVA antigen (Goldszmid et al.,
2009). The ERADmachinery recruitment to the PV seems depen-
dent on the Sec22b SNARE protein (Cebrian et al., 2011), but the
role of Sec22b on presentation of the membrane-bound GRA6
will have to be investigated. Characterization of the post-vacu-
olar export pathway(s) for this category of antigens represents
an exciting challenge for the coming years.
Why is presentation impaired by the IVN? The IVNmay trap the
antigen away from aC terminus-cleaving enzyme and act by ste-
ric hindrance. Alternatively, the high membrane curvature and/or
lipid composition of the IVNmay alter the translocation activity of
a membrane-embedded ‘‘translocon.’’ Rather than being inert
bystander components, membranes can regulate protein func-
tion, especially the activity of translocases (Van Voorst and De
Kruijff, 2000). This tuning may be driven by altered lateral pres-
sure leading to structural rearrangements (Cantor, 2002). For
instance, the lipid composition of the surrounding membranes
affects lateral pressure on membrane-anchored helices of the
TAP transporter and modulates its peptide transport activity
(Scho¨lz et al., 2011). Even though the T. gondii translocon(s) re-
main(s) to be identified, our data are consistent with the notion
that membrane deformations of the PV are key regulators of
this machinery. It will be useful to test the impact of IVN deletion
on the trafficking of exported T. gondii effectors (Bougdour et al.,
2014), especially those known to be membrane bound.
To date, the parameters known to favor immunogenicity of
T. gondii antigens are active secretion in cells infected by live
parasites (Dupont et al., 2014; Gregg et al., 2011; Kwok et al.,
2003), C-terminal position within the source antigen (Feliu
et al., 2013), and dense-granule-mediated (as opposed to rhop-
try-mediated) release (Grover et al., 2014). Additionally, some
secreted effectors associated with the IVN or the PV membrane
can regulate the MHC class I pathway (L.M.R., B.A.F., V. Cantil-
lana, G.A. Taylor, and D.J.B., unpublished data). Our work iden-
tifies two parameters promoting immunogenicity: association
with vacuolar membranes and absence of IVN. These findings
could help harness more effectively the potential of T. gondii
as a vaccine vector, especially in the anti-tumor vaccination
context. In pioneering studies, an attenuated strain of T. gondii
was shown to promote anti-tumor immunity largely due to
its strong adjuvant effect (Baird et al., 2013a, 2013b). It will
be important to test whether expressing tumor antigen(s) in
T. gondii, in the most immunogenic context defined here, could
boost specific anti-tumor T cell responses and potentiate
rejection.
Remarkably, the IVN of T. gondii is not the only example of
membranous tubular structures present at the interface between
an intracellular pathogen and its host. During both their intra-he-
patic and intra-erythrocytic cycles,Plasmodium parasites trigger
the formation of an exomembranous network of tubules (called
the tubovesicular network; TVN) irradiating from the PV in the in-
fected cell. In contrast to T. gondii, the effectors controlling TVN
biogenesis remain elusive, but its dynamical and morphological
properties, both at the blood (Hanssen et al., 2010) and liver
stages (Gr€utzke et al., 2014), have been studied. The Plasmo-
dium TVN is typically viewed as an exchange platform that could
either promote export of parasite components to the host and/or
facilitate lipid acquisition. Its potential role in MHC I presentation
by infected hepatocytes remains to be investigated. Another
example is the Salmonella bacteria, which induce the formation
of long membranous tubules (called SIT for Salmonella-induced
tubules) extending from the Salmonella-containing vacuole into
(G) Western blot analysis showing the expression level of GRA6 in the parental and GRA2-deficient TgPru parasites, revealed with the anti-HF10 antiserum and
SAG1 as a loading control.
(H) Western blot analysis showing the expression level of SAG1-OVA and GRA2 in the parental and GRA2-deficient TgRH YFP SAG1-OVA tachyzoites, revealed
with the anti-OVA and anti-GRA2 antibodies.
(I) Proportion of YFP+ BMM (i.e., infected cells) out of live BMM measured 6 hr post-infection.
(J) Kb-SL8 presentation by BMM infected for 8 hr with the indicated parasites, assessed with the B3Z hybridoma.
Data indicate mean ± SD. Data depicted on all panels are representative of three to five independent experiments.
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the host cell (Schroeder et al., 2011). SIT include at least three
categories of tubules characterized by distinct morphologies
and marker proteins (Krieger et al., 2014). Several effectors
contributing to tubule biogenesis have been identified (Brumell
et al., 2002), and the use of advanced imaging approaches has
brought unprecedented insight on the ultrastructuralmorphology
Figure 5. Immunization with T. gondiiDevoid of IVN Enhances the T Cell Response toMembrane-Bound GRA6 but Does Not Affect the T Cell
Response to Tgd057
(A) Description of the prime/boost immunization protocol and the ex vivo T cell response measurements. B6D2 F1 mice were immunized twice with irradiated
TgRH GRA6-HF10, TgRH GRA6-HF10 Dgra2, or TgRH GRA6-HF10 Dgra2/GRA2 parasites and analyzed 4 days after the second immunization. D, day.
(B and C) Ex vivo IFNg intracellular staining of splenocytes (B) or peritoneal exudate cells (C) restimulated with the GRA6-derived HF10 or the Tgd057-derived
SVL8 peptide. Bars represent the mean ± SEM. *p < 0.05; **p < 0.005. Data are pooled from two independent experiments.
(D) Solubility profile of endogenous Tgd057 in TgRH GRA6-HF10 after mechanical disruption of overnight-infected HFF. Western blot (WB) analysis of Tgd057
present in LSS, HSP (insoluble, membrane bound), and HSS (soluble) fractions. Data are representative of three separate experiments.
(E) Subcellular localization of the endogenous Tgd057 protein in parallel with GRA1 (vacuolar lumen) and GRA5 (PV membrane) markers. Scale bars, 5 mm.
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of SIT (Krieger et al., 2014). Formation of SIT correlates with
bacteria intracellular fitness, but the precise benefit of these
structures for the bacteria is uncertain, and whether they are
involved in MHC class I presentation is unknown.
Several features distinguish the Salmonella, T. gondii, and
Plasmodium membranous networks in terms of morphology,
protein content, and dynamics. A major difference is that
both the Salmonella SIT and the Plasmodium TVN are external
with respect to the compartment in which the pathogen de-
velops, while the T. gondii IVN is made of intravacuolar mem-
branes. However, it is likely that findings in one system could
inspire research on another pathogen and advance our under-
standing of these mysterious structures. Our present work sug-
gests that the T. gondii IVN plays a role in immune modulation
by interfering with the MHC class I pathway. These data pave
the way for investigating how such membrane networks may
influence antigen presentation in other intracellular pathogen
infections.
EXPERIMENTAL PROCEDURES
Ethics Statement
Animal studies were carried out under the control of the National Veterinary
Services and in accordance with the European Economic Community regula-
tions (EEC directive 86/609, dated November 24, 1986). The protocol was
approved by the Regional Ethics Committee of the Midi-Pyre´ne´es Region
(Approval MP/01/29/09/10).
Mice, Parasites, and Antibodies
C57BL/6JxDBA/2 F1 (B6D2) mice were purchased from Janvier and housed
under specific pathogen-free conditions. Sex- and age-matched (8- to
12-week-old) mice were used. All parental and transgenic T. gondii strains
used in this studyweremaintained by serial passages on confluentmonolayers
of human foreskin fibroblasts (HFF; ATCC SCRC-1041) and are listed in Table
S1. Antibodies for flow cytometry were rat anti-CD8 (53-6.7) and mouse anti-
IFN-g (XMG1.2) (eBioscience). Primary antibodies for western blot and immu-
nofluorescence were rabbit anti-Tgd057 serum and purified rabbit anti-HF10
serum (custom made, Biotem); rabbit anti-OVA (Sigma); and mouse mono-
clonal antibodies (mAbs) anti-SAG1 (TP3, Santa Cruz Biotechnology),
Figure 6. Disruption of the IVN Does Not Increase Solubility of the T. gondii Dominant Antigen GRA6 but Enhances Its Presence at the PV
Membrane
(A) Solubility profile of GRA6-HF10, with or without GRA2. Western blot (WB) analysis of GRA6-HF10 present in LSS, HSP (insoluble, membrane bound), or HSS
(soluble) fractions using the anti-HF10 antiserum. Histograms show the HSP over HSS ratio for one out of three experiments with similar results.
(B) Subcellular localization of GRA6-HF10 in HFF infected for 15 hr with TgRHGRA6-HF10 or TgRHGRA6-HF10 Dgra2 tachyzoites, visualized with the anti-HF10
antiserum. One confocal z section of a representative z stack is shown for each genotype. Gray indicates region of interest (ROI) 1, encompassing the entire PV;
blue indicates ROI2, internal content.
(C) Proportion of HF10 fluorescence in the vicinity of the PVmembrane (i.e., ROI1minus ROI2) over the total HF10 fluorescence within the PV (i.e., ROI1). Each dot
represents the median value of three ratio measurements, performed on three middle sections of a single PV. **p < 0.005. mb, membrane.
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anti-GRA2 (TG17.179), anti-GRA1 (TG17.43), anti-GRA3 (T62H11), and anti-
GRA5 (TG17.113)—the latter four produced by Biotem.
Plasmid Constructs and Parasite Transfection
Parasite transfections were performed as previously described (Feliu et al.,
2013). The protocols used for the generation of each plasmid and parasite
mutant are available in the Supplemental Experimental Procedures.
Western Blot and Subcellular Fractionation
Tachyzoites were released from infected HFFwith a 23G needle and lysedwith
1% Nonidet P-40 and protease inhibitors (cOmplete EDTA-free, Roche) for
30 min on ice. Lysates were centrifuged for 15 min at 15,000 3 g. Proteins
were reduced, separated by electrophoresis, and transferred to nitrocellulose
membranes. Immunologic detection was performed using horseradish-perox-
idase-conjugated antibodies (Promega) and quantified using a ChemiDoc sys-
tem (Bio-Rad).
The solubility profile of GRA proteins within the PV was examined by cell
fractionation of overnight-infected cells. Both the host cell and the PV mem-
branes were mechanically disrupted by passing infected HFF through 25G
needles, and released parasites were eliminated by a 2,0003 g centrifugation.
The soluble fraction (high-speed supernatant; HSS) was separated from the
membrane-associated fraction (high-speed pellet; HSP) by further centrifuga-
tion at 100,0003 g for 1 hr of the low-speed supernatant (LSS). Equal fractions
of HSP and HSS were analyzed by immunoblot.
BMM and BMDC Differentiation and Antigen Presentation Assays
These experiments were performed as previously described (Feliu et al., 2013).
Details can be found in the Supplemental Experimental Procedures.
Ex Vivo Analysis of T Cell Response
Mice were immunized twice 3 weeks apart with 2 3 106 tachyzoites that were
previously g-irradiated (120 Gy) and filtered through a 3-mm filter (Millipore).
Mice were euthanized 4 days after the second immunization. Peritoneal
exudate cells (PEC) were recovered by lavage with 10 ml cold PBS. Spleens
were dissociated into single-cell suspensions in complete RPMI medium.
Samples were depleted of erythrocytes, and production of IFN-g was
measured as described previously (Feliu et al., 2013). Samples were run on
an FC500 (Beckman-Coulter) or a Fortessa (Becton Dickinson) flow cytometer
and analyzed using the FlowJo software.
Immunofluorescence
Monolayers of HFF grown on Lab-Tek II chamber slides CC2 (Thermo Scien-
tific Nunc) were infected with T. gondii for 16 to 24 hr. After infection, cells were
washed with PBS, fixed for 20 min in 3% paraformaldehyde (Electron Micro-
scopy Sciences) at room temperature (RT), and quenched for 5 min with
PBS plus 0.1 M glycine. Primary antibodies were diluted in permeabilization
buffer (PBS, 0.2% BSA, 0.05% saponin) and incubated for 1 hr at RT followed
by three 5-min washes. Cells were incubated with AF555-coupled anti-rabbit
immunoglobulin G (IgG) and AF633-coupled anti-mouse IgG (Invitrogen) for
20 min at RT. z stacks were acquired on a Zeiss LSM710 confocal microscope
and analyzed using ImageJ software (NIH). For more details on the quantifica-
tion of the GRA6 signal, see the Supplemental Experimental Procedures.
Lipid Extraction, Lipid Binding, and Tubulation Assays
Lipids were extracted from 103 150 cm2 confluent flasks of HeLa cells (ATCC,
CCL-2); glycerolipids were quantified after methanolysis, as previously
described (Botte´ et al., 2008) and prepared as unilamellar vesicles, as detailed
in the Supplemental Experimental Procedures. The protocols for detergent-
free purification of rGRA2, rGRA2 DAAH, and rGRA6 proteins and their valida-
tion are described elsewhere (Bittame et al., 2015). For the protein-lipid overlay
assays (fat blots), nitrocellulose membranes spotted with different lipids (100
pmol per spot) (Lipid Membrane Strips, Echelon Biosciences) were blocked
for 1 hr with 3% fatty-acid-free BSA (FAF-BSA, Sigma-Aldrich) in TBS-T
(Tris-buffered saline with 0.1% Tween 20) and incubated overnight at 4C
with 0.1 mg/ml of rGRA2 or rGRA2 DAAH diluted in TBS-T, 3% FAF-BSA.
Following six washes in TBS-T, the proteins bound to lipids were revealed
by immunoblot with specific antibodies against GRA2.
LUV-recombinant proteins incubation products were analyzed by flotation
on a discontinuous sucrose gradient. Six micrograms of each recombinant
protein were incubated for 30 min at RT with LUV formed from 160 mg of lipids,
in 10 mM HEPES ( pH 7.4), 150 mM NaCl. Sixty-five microliters of the binding
mixture was mixed with 65 ml of 80% sucrose, loaded at the bottom of a
0.65-ml opened tube (Beckmann) and overlaid with five concentrations of su-
crose (30% to 0%). Following a 100,000 3 g centrifugation for 13 hr at 4C,
fractions were collected from the top of the gradient and analyzed by immuno-
blot. The phospholipids’ unsaturated fatty acids were revealed by fumigation
with iodine (Sigma-Aldrich).
For in vitro tubulation assays, 2–3 ml of each sample were adsorbed on
the clean side of a carbon film that had been pre-evaporated on a mica
sheet. The carbon film was detached from the mica by floating it in a well
containing the negative stain solution. The carbon film was picked up
onto a 400-mesh copper grid and air dried before observation with a
JEOL 1200 EX II operating at 100 kV. All samples were stained with 2%
(w/v) uranyl acetate. Images were recorded at the nominal magnifications
of 10,0003 or 40,0003.
Statistical Analyses
The Prism software (GraphPad) was used for statistical analyses. All p values
were calculated with the two-tailed non-parametric Mann-Whitney test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.11.001.
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